Business Context and Reporting Period
This Form 8-K filing by Chemed Corporation reports on the results of its annual meeting of shareholders held on May 16, 2016. The filing details the election of directors and the outcomes of shareholder votes on corporate governance and compensation matters.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
As this report covers a specific event (the annual meeting) rather than a financial period, there are no material changes to financial metrics to report. The primary changes are the formal election of the Board of Directors and the ratification of corporate policies.
Shareholder Vote Results and Governance
- Election of Directors: All 10 nominees were elected to the Board of Directors. Votes ranged from approximately 96.8% to 98.3% "For" each nominee.
- Stock Incentive Plans: Shareholders approved the re-approval of performance objectives for the 2006 and 2010 Stock Incentive Plans and Target Bonus Program with 98.32% of votes cast in favor.
- Ratification of Auditors: The appointment of PricewaterhouseCoopers LLP as the independent auditor for the year ending December 31, 2016, was ratified with 98.93% of votes cast in favor.
- Executive Compensation: The non-binding proposal to approve the executive compensation program was approved with 96.89% of votes cast in favor.
Investor Verification Checklist
- Verify the composition of the newly elected Board of Directors against the company's latest proxy statement.
- Confirm the specific performance metrics approved for the 2006 and 2010 Stock Incentive Plans in the accompanying proxy materials.
- Review the full text of the executive compensation proposal to understand the specific policies approved by shareholders.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial performance.